GRC and Total Data Centre Solutions Partner to Expand Data Centre Liquid Immersion Cooling in Europe
20.10.2020 09:00:00 EEST | Business Wire | Press release
GRC (Green Revolution Cooling), the single-phase immersion-cooling authority® for data centres, today announces a new partnership contract with Total Data Centre Solutions (TDCS), a leading provider of mission critical and innovative infrastructure solutions for Data Centres throughout Europe and the Nordic region focused on carbon reduction and energy efficiency.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005928/en/
GRC ICEraQ immersion-cooling system with rack-mounted service rails for easy maintenance and hot swaps. (Photo: Business Wire)
Through the partnership, TDCS will act as the agent for GRC in Europe, selling GRC’s ICEraQ® Micro-Modular, Rack-Based Immersion-Cooling Systems and ICEtank® Modular, Containerised data centres to clients primarily in the UK, the Nordic region, Germany and Luxembourg. Additionally, this new partnership now enables GRC to engage and support European data centre customers with a local European presence.
“GRC is delighted to partner with TDCS,” said Jim Weynand, Chief Revenue Officer, GRC. “The proliferation of AI, 5G, Edge computing, reduced carbon emissions, and more throughout Europe present new challenges for both legacy and new data centre builds. Our partnership with TDCS will ensure clients throughout Europe can seamlessly integrate immersion cooling into their existing infrastructures.”
After thoroughly assessing various immersion cooling solutions on the market, TDCS recognized that GRC’s immersion-cooling technology is a differentiator that brings value to their existing and potential clients. European clients can now acquire GRC’s immersion-cooling systems through TDCS in order to reduce energy use or power consumption, solve power and space density challenges, cut energy cooling costs significantly and place HPC compute close to where it’s needed and secure other benefits of GRC’s game-changing immersion-cooling solutions. Being the longest established immersion cooling company, with 11+ years’ experience and many blue-chip clients including The US Government, the US Air Force, and approved by most global server manufacturers – take out the fan and reap all the awards.
“It’s exciting to build this new partnership with GRC,” said Jonathan Evans, Founder of TDCS. “Joining GRC as an agent partner is an opportunity for us to offer clients best-of-breed single-phase liquid immersion cooling technology. We are passionate about reducing the carbon footprint and the OpEx of each, of our clients. The partnership of GRC and TDCS helps solve carbon and cost issues facing all data center owners and operators, which perfectly complements our sustainability portfolio of offerings from technologies to data centres."
About GRC
GRC is the immersion cooling authority®. The company's patented immersion-cooling technology radically simplifies deployment of data centre cooling infrastructure. By eliminating the need for chillers, CRACs, air handlers, humidity controls and other conventional cooling components, enterprises reduce their data centre design, build, energy, and maintenance costs. GRC’s solutions are deployed in seventeen countries and are ideal for next-gen applications platforms, including artificial intelligence, blockchain, HPC, 5G, and other Edge Computing and core applications. Their systems are environmentally resilient, sustainable, and space saving, making it possible to deploy the solution in virtually any location with minimal lead time. Visit http://grcooling.com for more information.
About Total Datacentre Solutions
TDCS is an End to End Data Centre Consultancy, founded in 2002. Specialising in reducing a client’s IT carbon footprint and CapEx/OpEx with new technologies. TDCS comprises a team of data centre business professionals, many with 30+ years of industry experience. Our aim is to provide clients with innovative technologies to help reduce their carbon footprints and optimize their CapEx/OpEx. Visit https://www.totaldatacentresolutions.co.uk for more information
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005928/en/
Contact information
Milldam Public Relations
Adam Waitkunas
978-828-8304 (mobile)
adam.waitkunas@milldampr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 11:00:00 EEST | Press release
Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom